Yahoo Web Search

Search results

1. Akebia Therapeutics, Inc.

   NasdaqCM: AKBA

   1.4800

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   +0.0600 (+4.23%)

   At close: Tue. Sep 10, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	1.4200
     High	1.4900
     Low	1.4100

   • Mkt Cap	311.23M
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	1.4200
     52 Wk. Low	0.7800
     52 Wk. High	2.4800

   More about AKBA

   Related stocks

   • ARDX
     Ardelyx, Inc.
     ARDX
     5.69
     0.00%
   • FGEN
     FibroGen, Inc.
     FGEN
     0.4000
     +1.32%
   • KPTI
     Karyopharm Therapeutics Inc.
     KPTI
     0.7249
     -1.41%
   • ADVM
     Adverum Biotechnologies, Inc.
     ADVM
     7.18
     +3.16%
   • ALDX
     Aldeyra Therapeutics, Inc.
     ALDX
     5.93
     +0.34%

   More on Yahoo Finance

2. stockanalysis.com › stocks › akbaAkebia Therapeutics, Inc. (AKBA) - Stock Analysis

   stockanalysis.com › stocks › akba

   • Cached

   Aug 28, 2024 · Get a real-time Akebia Therapeutics, Inc. (AKBA) stock price quote with breaking news, financials, statistics, charts and more.

   • Day's Range: 1.480-1.580
   • Previous Close: 1.470

   • Open: 1.520
   • Volume: 2,733,876

3. finance.yahoo.com › news › heres-why-consider-buyingHere's Why You Should Consider Buying Akebia (AKBA) Stock

   finance.yahoo.com › news › heres-why-consider-buying

   • Cached

   Aug 26, 2024 · Here, we discuss some reasons why buying Akebia (AKBA) stock now may turn out to be a prudent move.

4. finance.yahoo.com › news › akebia-therapeuticsAkebia Therapeutics to Present at Upcoming Investor Conferences

   finance.yahoo.com › news › akebia-therapeutics

   • Cached

   Aug 26, 2024 · Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that its executives will ...

5. stockanalysis.com › stocks › akbaAkebia Therapeutics, Inc. (AKBA) Stock Forecast & Price ...

   stockanalysis.com › stocks › akba

   • Cached

   5 days ago · The 2 analysts with 12-month price forecasts for Akebia Therapeutics stock have an average target of 5.75, with a low estimate of 4.00 and a high estimate of 7.50. The average target predicts an increase of 325.93% from the current stock price of 1.35.

6. www.marketbeat.com › stocks › NASDAQAkebia Therapeutics (AKBA) Stock Price, News & Analysis

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   2 days ago · Should You Buy or Sell Akebia Therapeutics Stock? Get The Latest AKBA Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat.

   • 3.7/5
   • Phone: (617) 871-2098

   • Location: 245 FIRST STREET SUITE 1100, CAMBRIDGE MA, 02142
   • Email: ir@akebia.com

7. www.marketbeat.com › stocks › NASDAQAkebia Therapeutics (AKBA) Stock Forecast & Price Target

   www.marketbeat.com › stocks › NASDAQ

   • Cached

   5 days ago · AKBA's current price target is $5.75. Learn why top analysts are making this stock forecast for Akebia Therapeutics at MarketBeat.

8. People also ask

   What does Akba stand for?

   • CAMBRIDGE, Mass. , July 29, 2024 /PRNewswire/ -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, tod...

   Akebia Therapeutics, Inc. (AKBA) - Stock Analysis

   stockanalysis.com/stocks/akba/

   See all results for this question

   How much is Akebia Therapeutics (Akba) stock now?

   • As of January 1st, 2024, Akebia Therapeutics' stock was trading at $1.24. Currently, AKBA shares are trading at $1.12, having decreased by 9.7% since then. View the best growth stocks for 2024 here. When is Akebia Therapeutics' next earnings date?

   Akebia Therapeutics (AKBA) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/nasdaq/akba/

   See all results for this question

   Should I buy AKBA (Akba) stock?

   • According to three stock analysts, AKBA stock has a "Strong Buy" average rating. This suggests that analysts believe this stock is likely to perform well in the near future and significantly outperform the market.

   Akebia Therapeutics Stock Forecast - Stock Analysis

   stockanalysis.com/stocks/akba/forecast/

   See all results for this question

   What are analysts' Akba share price targets?

   • The predicted share price targets for AKBA range from $4.00 to $6.00. On average, analysts predict the company's share price to reach $5.00 in the next year. This suggests a possible upside of 346.4% from the stock's current price.

   Akebia Therapeutics (AKBA) Stock Price, News & Analysis - MarketBeat

   www.marketbeat.com/stocks/nasdaq/akba/

   See all results for this question

9. finance.yahoo.com › news › akebia-therapeuticsAkebia Therapeutics Reports Inducement Grants Under Nasdaq ...

   finance.yahoo.com › news › akebia-therapeutics

   • Cached

   Sep 3, 2024 · Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, granted one newly-hired employee options to ...